More about

Ulcerative Colitis

News
May 27, 2022
2 min read
Save

Impaired humoral, upheld cellular responses in patients with IBD after SARS-CoV-2 vaccine

SAN DIEGO — Though patients with inflammatory bowel disease have impaired humoral response after SARS-CoV-2 vaccinations, cellular responses were maintained and comparable to those of health care workers, according to study results.

News
May 26, 2022
6 min watch
Save

VIDEO: Tremfya safe, efficacious for moderately to severely active Crohn’s

VIDEO: Tremfya safe, efficacious for moderately to severely active Crohn’s

SAN DIEGO — In this video exclusive, Remo Panaccione, MD, of the University of Calgary, discussed a study assessing the safety and efficacy of Tremfya in patients with moderately to severely active Crohn’s disease.

News
May 25, 2022
2 min read
Save

Herpes zoster incidence higher among patients with IBD vs. general population

Herpes zoster incidence higher among patients with IBD vs. general population

SAN DIEGO — Patients with inflammatory bowel disease had a higher incidence of herpes zoster than the general population, demonstrating a need for preventive measures, according to research presented at Digestive Disease Week 2022.

News
May 24, 2022
3 min read
Save

Interactive decision aid fails to best standard education for biologic selection in IBD

SAN DIEGO — A novel tool for educating patients with inflammatory bowel disease on biologic therapies failed to improve upon standard education with regard to shared decision-making, according to data presented at Digestive Diseases Week.

News
May 24, 2022
2 min read
Save

Survey results suggest Black patients face greater barriers to IBD treatment

Survey results suggest Black patients face greater barriers to IBD treatment

SAN DIEGO — Black patients with inflammatory bowel disease were more likely to use older therapies and face continued barriers to effective care, according to survey results presented at Digestive Disease Week 2022.

News
May 24, 2022
12 min read
Save

‘Just pick up the phone’: The case for cross-specialty coordination in AS, IBD

‘Just pick up the phone’: The case for cross-specialty coordination in AS, IBD

Sometimes, the best way to care for a patient is to know one’s own limitations.

News
May 24, 2022
1 min read
Save

Researchers observe no difference between subcutaneous and IV infliximab treatment in IBD

Researchers observe no difference between subcutaneous and IV infliximab treatment in IBD

SAN DIEGO — Subcutaneous infliximab maintained remission among patients with inflammatory bowel disease who switched from IV dosing, according to research presented at Digestive Disease Week.

News
May 21, 2022
1 min read
Save

Risk for fungal infections doubles with corticosteroid use vs. TNF-a inhibitors in IBD

SAN DIEGO — Corticosteroid use should be minimized in patients with inflammatory bowel disease to reduce the risk for invasive fungal infections, according to research presented at Digestive Disease Week 2022.

News
May 21, 2022
2 min read
Save

Ozanimod produces favorable long-term cardiac safety profile in UC, MS

Ozanimod produces favorable long-term cardiac safety profile in UC, MS

SAN DIEGO — Minimal long-term cardiac safety findings were reported with ozanimod treatment in patients with ulcerative colitis and relapsing multiple sclerosis, according to research presented at Digestive Disease Week 2022.

News
May 16, 2022
2 min read
Save

Antibiotic use linked with an increased risk for older-onset IBD

Antibiotic use linked with an increased risk for older-onset IBD

The use of antibiotics, particularly those targeting gastrointestinal pathogens, was associated with an increased risk for older-onset inflammatory bowel disease, according to a researcher at the Digestive Disease Week 2022 media briefing.

View more